CellTrans’ Donislecel Gets US FDA Panel Nod For Small Group Of Type 1 Diabetics

 
• By Sue Sutter
  
Independence Day fireworks
Some recipients of CellTrans' donislecel are able to celebrate years of independence from insulin. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers